MedAware, an Israeli developer of big data analytics for the medical prescription market, announced that it has completed a $1 million Series A financing round led by equity crowdfunding platform OurCrowd together with Geberal Electric‘s GE Ventures.
This marks the first time that GE has made an investment in Israel’s growing healthcare industry.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at firstname.lastname@example.org.
The money raised will be used by MedAware to drive initial sales to healthcare providers, insurance companies and large pharmacy chains.
MedAware declares that it provides innovative solutions that save lives, improve patient safety and significantly reduce healthcare costs, by identifying and preventing prescription errors in real-time. MedAware’s patent-pending technology uses big data analytics and machine learning algorithms to analyze large scale data of Electronic Medical Records (EMRs), to learn automatically how physicians treat patients in real life scenarios.
Prescriptions largely deviating from the spectrum of standard treatment patterns are flagged as potential errors with high specificity and low “alert fatigue”. MedAware was founded in 2012, and is headquartered in Israel. The company is led by an expert team with extensive clinical, business and technical experienc
Today, prescription errors result in morbidity, mortality and wasteful healthcare costs, harming hundreds of thousands of people annually in the United States alone. To combat the prevalence of those errors, MedAware has developed an innovative software-based solution that combines the power of big data analytics and machine learning to save lives and reduce medical costs.
“Three years ago I came across a tragic case of a nine-year-old Israeli boy who died because his primary-care physician accidentally prescribed the wrong drug, ” said MedAware Co-founder and CEO Gidi Stein. “The ease with which a little boy died because of a mistaken click of a button was horrifying to me as a physician and as a parent. We have founded MedAware in order to try and prevent such cases.”
Current solutions such as electronic medical records and computerized physician order entry systems search for prescription errors based on manually predefined rules. These systems miss errors that do not fall into their known rules, and also suffer from high false-alarm rates. By contrast, MedAware uses big-data analytics and machine-learning algorithms to automatically learn how different clinical scenarios are managed by physicians in real world situations.
“MedAware embodies many of the same technologies we’ve seen accompany the emergence of the Industrial Internet, ” added Jason Sibley, Director of Healthcare Ventures at GE Ventures. “From big data and analytics to machine learning and digital communications, the company aligns perfectly with GE’s vision for a healthcare industry driven by technology and built for improving lives, and we look forward to working together to help transform the medical prescription market.”
“We are excited about the potential for MedAware to solve the huge problem of prescription error via their impressive big data technology, ” said Jon Medved, founder and CEO of OurCrowd. “The fact that our partner, General Electric, has joined together with us in this investment is further validation of this tremendous opportunity.”